<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>RATIONALE: Reflux of gastric and duodenal contents in patients with <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) has been postulated as a major cause of complications, such as <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> or malignant degeneration </plain></SENT>
<SENT sid="1" pm="."><plain>FINDINGS: We present a summary of experimental, clinical, and immunohistochemical studies that show that acid and <z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">bile reflux</z:e> are increased in patients who suffer from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, are the key factor in the pathogenesis of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and are possibly related to the development of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>